Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening.

作者: David Cella , Elizabeth A. Hahn , Kelly Dineen

DOI: 10.1023/A:1015276414526

关键词:

摘要: Introduction: There has been increased recent attention to the clinical meaningfulness of group change scores on health-related quality life (HRQL) questionnaires. It assumed that improvements and declines comparable magnitude have same meaning or value. Method: We assessed 308 cancer patients with Functional Assessment Cancer Therapy (FACT) a Global Rating Change. Patients were classified into five levels in HRQL its dimensions based upon their responses retrospective ratings after 2 months: sizably worse, minimally no change, better, better. Raw score standardized changes FACT-G subscales total then compared across different categories patient-rated change. Results: The relationship between actual FACT was modest but usually statistically significant (r: 0.07 0.35). Change associated each rating category evaluated determine estimates meaningful difference. who reported global worsening had considerably larger than those reporting improvements. Although related ceiling effect, this remained true even removing cases began near questionnaire. Discussion: Relatively small gains Comparable may be less meaningful, perhaps due patients' tendency minimize personal negative evaluations about one's condition. This important implications for interpretation Factors such as adaptation disease, response shift, dispositional optimism need signs improvement contributing results should investigated future studies.

参考文章(46)
Neil K. Aaronson, Quality of Life Assessment in Cancer Clinical Trials Springer, Berlin, Heidelberg. pp. 97- 113 ,(1990) , 10.1007/978-3-642-46695-3_11
Janice A. Husted, Richard J. Cook, Vern T. Farewell, Dafna D. Gladman, Methods for assessing responsiveness: a critical review and recommendations Journal of Clinical Epidemiology. ,vol. 53, pp. 459- 468 ,(2000) , 10.1016/S0895-4356(99)00206-1
Bonomi Ae, Cella Df, Measuring quality of life: 1995 update. Oncology. ,vol. 9, pp. 47- 60 ,(1995)
Wendy L. Ward, Elizabeth A. Hahn, Fei Mo, Lesbia Hernandez, David S. Tulsky, David Cella, Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument Quality of Life Research. ,vol. 8, pp. 181- 195 ,(1999) , 10.1023/A:1008821826499
P R Baker, J Groh, G A Wells, G R Kraag, D A Redelmeier, P Tugwell, Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. The Journal of Rheumatology. ,vol. 20, pp. 557- 560 ,(1993)
Roman Jaeschke, Joel Singer, Gordon H. Guyatt, Measurement of health status: Ascertaining the minimal clinically important difference Controlled Clinical Trials. ,vol. 10, pp. 407- 415 ,(1989) , 10.1016/0197-2456(89)90005-6
M J Brady, D F Cella, F Mo, A E Bonomi, D S Tulsky, S R Lloyd, S Deasy, M Cobleigh, G Shiomoto, Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. Journal of Clinical Oncology. ,vol. 15, pp. 974- 986 ,(1997) , 10.1200/JCO.1997.15.3.974
S B Yellen, D F Cella, Someone to live for: social well-being, parenthood status, and decision-making in oncology. Journal of Clinical Oncology. ,vol. 13, pp. 1255- 1264 ,(1995) , 10.1200/JCO.1995.13.5.1255
D Osoba, G Rodrigues, J Myles, B Zee, J Pater, Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology. ,vol. 16, pp. 139- 144 ,(1998) , 10.1200/JCO.1998.16.1.139